Here the authors describe the different ways that cancer cells evade the immune system and how these mechanisms impact immunoediting and tumour clonality. They suggest that in tumours that become highly heterogeneous, presentation of subclonal antigens can result in immune evasion and may explain their poor prognosis and response to immunotherapy.
- Malte Roerden
- Stefani Spranger
